advertisement
Stalmans I 10
Showing records 1 to 10 | Display all abstracts from Stalmans I121436 Treatment Outcomes Comparing the Paul and Baerveldt Glaucoma Implants After One Year of Follow-Up
Berteloot S
Journal of Glaucoma 2024; 33: 594-600
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Erb C; Topouzis F
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
121436 Treatment Outcomes Comparing the Paul and Baerveldt Glaucoma Implants After One Year of Follow-Up
Correia Barão R
Journal of Glaucoma 2024; 33: 594-600
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Jayaram H
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
121436 Treatment Outcomes Comparing the Paul and Baerveldt Glaucoma Implants After One Year of Follow-Up
Abegão Pinto L; Vandewalle E
Journal of Glaucoma 2024; 33: 594-600
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Allan F
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
121436 Treatment Outcomes Comparing the Paul and Baerveldt Glaucoma Implants After One Year of Follow-Up
Stalmans I
Journal of Glaucoma 2024; 33: 594-600
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Nisslé S
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
121436 Treatment Outcomes Comparing the Paul and Baerveldt Glaucoma Implants After One Year of Follow-Up
Lemmens S
Journal of Glaucoma 2024; 33: 594-600
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Muñoz-Negrete FJ; Stalmans I
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
